What ripple effects could that have across sectors
Read all product packaging for ingredients, suggested use, warnings, and other important information prior to use
10.3389/fimmu.2024.1361519 9 FlossmannO.BaconP.de GrootK.JayneD.RasmussenN.SeoP.et al (2007)
Methods 417 , 8696 (2015)
[1] Liraglutide can be prescribed for the treatment of obesity in adults with a body mass index (BMI) of 30 or higher, or a BMI of over 27 if they have at least one other weight related health condition (such as adults with type 2 diabetes, high cholesterol, high blood pressure, prediabetes, or obstructive sleep apnoea)
To view a copy of this licence, visit About this article Cite this article Terzi, A., Ngo, K.J